TAGLN2 and pulmonary arterial hypertension: Mediation analysis was conducted, using TAGLN2 as exposure variables, immune cells as the mediator, and PAH as the outcome (Table S14, Supplemental Digital Content, https://links.lww.com/MD/Q396).